We are proud to announce that Portfolia has been recognized by MedTech Outlook as one of the Top 10 MedTech VCs of 2024. This prestigious honor highlights our commitment to investing in innovative healthcare solutions that are transforming the lives of millions.
Since launching our first FemTech Fund in 2018, Portfolia has led the way in addressing unmet needs in women's health and active aging through venture capital. With over 45 investments in healthcare companies like Maven Clinic, Everly Health, and Hera Biotech, we are shaping the future of MedTech and advancing solutions for global health challenges.
At Portfolia, we believe that capital has the power to create meaningful change. This recognition underscores the success of our investment strategies, the strength of our portfolio companies, and the dedication of our incredible investors.
About the Award:
The MedTech Outlook Top 10 MedTech VCs award celebrates venture capital firms that demonstrate excellence in driving innovation, advancing MedTech solutions, and creating value for investors and patients alike.